[1]
Alejandro González Álvarez, Manuel Gómez Barrera, Joaquín Borrás Blasco, and Emilio José Giner Serret, “Adalimumab and Etanercept in the Treatment of Rheumatoid Arthritis and Spondyloarthropathies: Budget Impact Model of Dose Reduction ”, J. Pharm. Nutr. Sci., vol. 4, no. 3, pp. 170–176, Jun. 2014.